CORMORANT ASSET MANAGEMENT, LLC Information

100 HIGH STREET, SUITE 1105, BOSTON, Massachusetts, 02110, (617) 848-3429

Report Date: 12/31/2014

Position Statistics

Total Positions 75
New Positions 11
Increased Positions 27
Decreased Positions 16
Positions with Activity 43
Sold Out Positions 6
Total Mkt Value (in $ millions) 746

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.

Sector Weighting

Basic Materials
Capital Goods
Conglomerates 15.81%
Consumer Cyclical
Consumer/Non-Cyclical
Energy
Financial
Healthcare 57.78%
Services
Technology
Transportation
Utilities

43 Activity Positions as of 12/31/2014

Company Class Value of Shares ($1,000s) ▼ Change in Value ($1,000s) Change (%) Shares Held
RECEPTOS INC COM 102,720 -17,109 (14.28) 641,800
PUMA BIOTECHNOLOGY INC COM 52,747 -68,931 (56.65) 220,000
NEUROCRINE BIOSCIENCES INC COM 41,530 6,230 17.65 1,000,000
CELGENE CORP COM 36,006 36,006 New 300,000
OVASCIENCE INC COM 28,520 8,812 44.71 747,000
ALKERMES PLC SHS 28,134 21,882 350 450,000
PORTOLA PHARMACEUTICALS INC COM 23,100 15,400 200 600,000
SORRENTO THERAPEUTICS INC COM NEW 19,880 8,520 75 1,750,000
REGULUS THERAPEUTICS INC COM 18,986 15,534 450 1,100,000
QUOTIENT LTD SHS 17,600 9,600 120 1,100,000
BRISTOL MYERS SQUIBB CO COM 16,440 6,576 66.67 250,000
KITE PHARMA INC COM 15,295 9,297 155 255,000
CHIMERIX INC COM 15,160 5,685 60 400,000
ARDELYX INC COM 13,917 8,782 171.03 1,053,500
OMEROS CORP COM 13,038 770 6.28 582,300
ADVAXIS INC COM NEW 11,283 6,579 139.86 839,500
ACCELERON PHARMA INC COM 9,535 -5,721 (37.5) 250,000
CHINA BIOLOGIC PRODS INC COM 8,316 -462 (5.26) 90,000
ALDER BIOPHARMACEUTICALS INC COM 7,415 2,966 66.67 250,000
BIOCRYST PHARMACEUTICALS COM 6,856 -2,571 (27.27) 800,000